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Abstract
Background: Different mechanisms connect the nutritional status with the occurrence and the course of chronic
kidney disease (CKD). The end-stage renal disease is complicated by catabolic inflammatory reactions and cachexia
which leads to malnutrition (undernutrition). On the other hand, obesity is an important risk factor for the
development and acceleration of CKD.
Methods: In the SCOPE study, community-dwelling persons aged 75 years and over, from 6 European countries
and Israel were examined at the baseline phase. We assessed the relationship between anthropometric measures
(Body Mass Index (BMI), circumferences of arm (AC), waist (WC), hip (HC), and calf (CC), waist-to-hip ratio - WHR,
waist-to-height ratio - WHtR, risk of malnutrition (Mini Nutritional Assessment - MNA), serum albumin) and
estimated glomerular filtration rate (eGFR) calculated by Berlin Initiative Study (BIS) equation.
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Results: We studied 2151 subjects (932 men and 1219 women) with a mean age of 79.5 ± 5.9 years. A total of 1333
(62%) participants had CKD (GRF < 60 ml/min/1.73 m2). Negative correlations between eGFR and weight, AC, WC,
HC, CC, BMI, WHtR were observed. Positive correlation occurred between eGFR and MNA score (Spearman’s rho =
0.11) and albumin concentration (rho = 0.09). Higher weight, AC, WC, HC, CC, BMI and WHtR increased the odds
ratio of CKD; higher MNA (OR = 0.98, 95% CI 0.94–1.0) and higher serum albumin (OR = 0.73, 95% CI 0.53–1.0) were
weakly associated with reduced odds. The risk of malnutrition was the highest with eGFR < 30 as compared to
eGFR > 60 (OR = 2.95, 95%CI = 1.77–4.94 for MNA < 24; OR = 5.54, 95%CI = 1.66–18.5 for hypoalbuminemia < 3.5 g/
dL).
Conclusion: The population of community dwelling people aged 75+ with CKD shows general features of
overweight and obesity with a small prevalence of malnutrition. For anthropometric measures, the strongest
association with eGFR and the highest odds of CKD were identified using WC, HC, CC and WHtR. Albumin level and
MNA, but not MNA Short Form, indicated an increased odds of malnutrition with a decrease in eGFR.
Keywords: Aging, Chronic kidney disease, MNA, Malnutrition, Undernutrition, Overweight, Obesity
Background
In recent years, an increase in the prevalence of chronic
kidney disease (CKD) has been observed [1]. Currently,
in the European population, about 18% of citizens suffer
from CKD [2]. Similarly, the prevalence of obesity in the
worldwide population aged 65 years and older is between
18 and 30% [3, 4]. Not only obesity affects the elderly,
but more and more attention is also paid to the occur-
rence of malnutrition or undernutrition [5]. Depending
on the criterion used and setting, it occurs in about 10%
among independent people up to more than 60% in re-
habilitation hospitals and intensive care units [3].
Nutritional status defined as “the condition of the
body in those respects influenced by the diet; the levels
of nutrients in the body and the ability of those levels to
maintain normal metabolic integrity” [6] contributes to
the older people’s health status and risk of many dis-
eases. In older age this status is influenced by the cumu-
lative effect of comorbidities, functional status, medical
history and economic status. Hormonal, metabolic and
other changes may affect the nutritional status of the
elderly, predisposing to deviations from normality.
While the association between CKD and nutritional dis-
orders in the general population is well known [7], there is
a substantial lack of evidence with regard to older people
(i.e. the population more exposed to the burden of both
CKD and malnutrition) [8–10]. CKD may be associated
with relevant changes in appetite and taste perception, as
well as impaired thirst mechanism and increased risk of
dehydration [11]. All these changes may increase the risk
of malnutrition [12], which in turn may lead to functional
impairment [13, 14], sarcopenia and frailty [15], increased
risk of falls [16], hospitalization and mortality [17, 18]. On
the other hand, age-related hormonal changes together
with lower physical activity may promote obesity in the
older adults [19, 20]. Excessive body fat, especially visceral,
is associated with metabolic disorders and increased in-
flammation [21], CKD, hypertension and diabetes [22, 23].
In the Screening for Chronic Kidney Disease Among
Older People Across Europe (SCOPE) project a lot of at-
tention has been paid to the assessment of participants’
nutritional status [24]. The collected data allows reliable
and detailed analysis of the relationship between kidney
function and the nutritional status. The aim of our study
was to assess the relationship between anthropometric
measures, malnutrition and kidney function among older
adults aged 75 or more. Given that appropriate manage-
ment of older patients with CKD may contribute to
slower loss of kidney function (potentially preventing
kidney failure) and enable to control better over its con-
sequences [25, 26], understanding the cross-sectional in-
teractions between anthropometric measures, nutritional
status and CKD represents a relevant step in prevention
strategies.
Methods
Design of the study and study population
The SCOPE study (European Grant Agreement no.
436849), is a multicenter prospective cohort study in-
volving patients older than 75 years attending geriatric
and nephrology outpatient services in participating insti-
tutions in Austria, Germany, Israel, Italy, the
Netherlands, Poland and Spain. Only people aged 75 or
more were asked to participate because of the high
prevalence of CKD in this population [8, 27]. Methods
of the SCOPE study have been extensively described
elsewhere [24]. Briefly, all patients attending the out-
patient services at participating centers from August
2016 to August 2018 were asked to participate. Only pa-
tients signing a written informed consent entered the
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study. Age greater or equal to 75 years was the only in-
clusion criteria, the exclusion criteria were: end-stage
renal disease or dialysis at time of enrollment; history of
solid organ or bone marrow transplantation; active ma-
lignancy within 24months prior to screening or meta-
static cancer; life expectancy less than 6 months (based
on the judgment of the study physician after careful
medical history collection and diagnoses emerging from
examination of clinical documentation exhibited); severe
cognitive impairment (Mini Mental State Examination <
10); any medical or other reason (e.g. known or sus-
pected patients’ inability to comply with the protocol
procedure) in the judgement of the investigators, that
the patient was unsuitable for the study; unwilling to
provide consent and limited possibility to attend follow-
up visits. Enrolled patients underwent an extensive as-
sessment including: demographic data, socioeconomic
status, physical examination, comprehensive geriatric as-
sessment, bioimpedance analysis, diagnoses (clinical his-
tory and assessment of clinical documentation exhibited
by patients and/or caregivers), quality of life, physical
performance, overall comorbidity and blood and urine
sampling. Patients were followed-up for 24-months as
previously described [24]. The study protocol was ap-
proved by ethics committees at all participating institu-
tions, and complies with the Declaration of Helsinki and
Good Clinical Practice Guidelines. The study was regis-
tered at ClinicalTrials.gov (NCT02691546). Only base-
line data was used in the present study.
Overall, 2461 patients were initially enrolled in the
study, 310 participants were excluded because of
missing data in any of the study variables, leaving a
final sample of 2151 participants to be included in
the analyses.
Study variables
Each participating center used standardized measure-
ment methods in accordance with the study protocol.
Age, gender and country were considered in the
analysis.
Anthropometric measurements
Trained staff measured participants’ height and weight
using a weighing scale with height rod. Waist, hip, arm
and calf circumference were measured with a flexible
measuring tape to the nearest 0.1 cm according to the
WHO’s standard technique. Then, the Body Mass Index
(BMI) was calculated by dividing the subject’s weight in
kilograms by height in metres squared, Waist-to-Height
Ratio (WHtR) as WC divided by height and Waist-to-
Hip Ratio (WHR) as quotient of the circumference of
the waist to the hips.
Risk of malnutrition (undernutrition)
Nutritional status was assessed using the Mini Nutri-
tional Assessment (MNA) questionnaire. This is simple
and practical, non-invasive tool which is commonly used
by health professionals for early detection of risk of mal-
nutrition [28]. The MNA consists of 18 questions: 5 in
the screening part and 13 in the assessment part. The
total score ranges from 0 to 30, where a score of less
than 17 points indicates malnutrition, from 17 to 23.5
risk of malnutrition, and 24 or more points normal nu-
trition. The MNA is recommended by the ESPEN for
detecting the presence of malnutrition and the risk of
developing malnutrition among older adults [3].
Biochemical markers of nutritional status
Serum albumin was determined with the use of the bro-
mocresol green colorimetric assay and presented as g/dl
[29]. Albumin is a serum hepatic protein with half-life of
14–20 days. Serum albumin level suggesting malnutri-
tion was set at < 3.5 g/dL (hypoalbuminemia) [30].
Kidney function
Kidney function was measured, according to estimated
glomerular filtration rate (eGFR) category, based on the
GFR BIS equation, which is among the few equations
specifically developed and validated among people aged
70 or more [31, 32]:
3736 creatinine‐0:87  age‐0:95 0:82 if female½ 
Participants were divided into 4 groups presenting
stages of CKD: G1–2 (60 or more); G3A (45–59.9);
G3B (30–44.9); G4 (15–30), and were also dichoto-
mized as CKD(−) group (GFR ≥ 60) and CKD(+)
group (GRF < 60) [33].
Overall comorbidity
Overall comorbidity was assessed by Cumulative Illness
Rating Score for Geriatrics (CIRS-G) [34]. CIRS-G con-
sists of the assessment of the severity of coexisting dis-
eases in 14 organ/systems scales, each ranging from 0
(problem absent) to 4 (severe problem with requirement
of immediate treatment and/or severe organ/system
failure).
Diagnoses
Diabetes, cancer, hypertension, coronary artery disease
(CAD), cerebrovascular diseases (CVD), heart failure
(HF), chronic obstructive pulmonary disease (COPD),
and metabolic syndrome were also considered in the
analyses. The occurrence of selected diagnoses was
ascertained by the study physician through detailed col-
lection of medical history and examination of clinical
documentation exhibited by patients and caregivers
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during study visit as described above. Metabolic syn-
drome was defined on the basis of the International Dia-
betes Federation criteria as central obesity (based on
WC) plus any two of the following risk factors: plasma
triglycerides ≥150 mg/dl, HDL-cholesterol< 40 for men
and < 50 for women, blood pressure > 130/80 mmHg or
previous diagnosis of hypertension, fasting plasma glu-
cose> 100 mg/dl or previous diagnosis of diabetes [35].
Statistical analysis
All variables were checked for normality of distribution
by the Kolmogorov–Smirnov test. All the continuous
variables were not normally distributed, therefore they
were presented by median and interquartile difference.
Mann Whitney U-test was used to compare nutritional
status between CKD(+) and CKD(−) groups and between
men and women. Differences between subgroups, de-
pending on CKD stages, were assessed using the
Kruskal-Wallis and post hoc Dunn-Sidak test. Spearman
correlations between nutritional status indicators and
kidney function (eGFR) were calculated. Additionally,
test of homogeneity of the slopes (comparison of regres-
sion lines and ANOVA interactions) were used to cor-
roborate the different relationship of eGFR to nutritional
components according to sex.
Logistic regression (Odds ratios and corresponding
95% confidence intervals (95%CI)) was used to assess
which independent variables predicted the presence of
CKD (Model 1), malnutrition defined with MNA < 24
(Model 2) and malnutrition defined with albumin < 3.5
g/dL (Model 3). Each model was adjusted for age and
sex (A), age, sex, concomitant diseases (diabetes mellitus,
cancer, HF, CAD, CVD, COPD, metabolic syndrome)
and country (B).
Statistical significance was set at p < 0.05. All statis-
tical analyses were performed with SPSS version 24
(SPSS Inc., Chicago, IL, USA).
Results
We studied 2151 subjects (932 men) with median age
79.5 ± 5.9 years. A total of 1333 (62%) participants had
CKD (GRF < 60 ml/min/1.73 m2). Table 1 shows the
general characteristics of the participants divided by sex
and presence of CKD.
Women showed lower educational level than men, had
lower prevalence of diabetes mellitus, cancer, CAD,
CVD, HF, COPD, and lower CIRS-G score. Men had
higher weight, WHR, AC, WC, HC, CC and higher
MNA SF and MNA scores. Women were more frequent
among patients enrolled in Germany and Poland, while
people from Austria, Italy and the Netherlands were
more frequently men (Table 1).
Participants in the CKD(+) group were older, more
frequently men, less educated and with a higher
prevalence of chronic diseases, including metabolic syn-
drome. The nutritional status of subjects with CKD was
characterized by higher BMI, WHR, WHtR, weight and
AC, WC, HC and CC. The result obtained in the MNA
SF test did not differ between the groups, while the
MNA and albumin were significantly lower in the
CKD(+) group compared to patients without CKD. Fi-
nally, subjects with CKD were more frequent among pa-
tients enrolled in Austria and the Netherlands, while less
frequent among those enrolled in Israel, Poland and
Spain (Table 1).
Analysis of study variables across eGFR stages 1–4 by
sex (Table 2) showed that age increased and education
decreased together with reducing eGFR. Higher values
of anthropometric measures were observed among pa-
tients with more advanced CKD stages, while MNA and
albumin level decreased together with reducing eGFR.
Likewise, the prevalence of concomitant chronic diseases
and CIRS-G continually increased together with eGFR
stage. Finally, more advanced stages of CKD were espe-
cially prevalent among patients from Austria and the
Netherlands, while less frequent in Israel, Italy and
Poland (Table 2).
The correlations of eGFR with selected variables are
presented in Table 3. Negative correlations with age and
positive correlations with education level were found.
Negative correlations for all the nutritional anthropo-
metric variables (except for WHR - eGFR relationship in
men) with kidney function were observed. A positive
correlation occurred between eGFR and MNA score and
albumin concentration (Table 3).
Figure 1a-d shows the relationship of eGFR to selected
nutritional variables. Comparison of the slopes of re-
gression lines showed significant differences for eGFR
association to CC (Fig. 1a) and albumin levels (Fig.
1b) between men and women. In men, those associa-
tions were steeper than in women. For other nutri-
tional variables, those associations were similar in
both sexes. As an example, the relationship of eGFR
to WHtR has been shown in Fig. 1c and that to
MNA in Fig. 1d.
Age and sex adjusted regression models showed an in-
creased risk of CKD (defined as eGFR < 60) for higher
weight, AC, WC, HC, CC, BMI and WHtR, as well as a
decrease in the risk of CKD with higher MNA and
higher serum albumin. After further adjusting for co-
morbidities and country results remained substantially
unchanged (Table 4).
Finally, a graded association between CKD stage and
malnutrition defined with MNA < 24 or hypoalbumin-
emia was found in age- and sex-adjusted model. After
further adjustment for comorbidities and country, only
eGFR< 30 remained statistically associated with MNA <
24 or hypoalbuminemia (Table 4).
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Discussion
To the best of our knowledge, this is the first study to
analyze the relationship between nutritional status and
kidney function in community dwelling people aged 75+
not on dialysis and without ESRD. The results show a
clear association between nutritional status and eGFR in
this population. Findings about anthropometric mea-
sures generally point out that the severity of overweight
and obesity is related to the prevalence of CKD. Albu-
min and MNA, but not MNA SF, correlate with kidney
function and discriminate eGFR categories.
As other studies show [36], CKD is primarily associ-
ated with abdominal obesity. This type of obesity is
characterized by an increase of adipose tissue surround-
ing the intra-abdominal organs. This phenotype is asso-
ciated with metabolic disturbances and several chronic
diseases [37, 38]. One of them is metabolic syndrome.
There is growing evidence that metabolic syndrome is
significantly associated with the risk of rapid eGFR de-
cline [39, 40], and its high prevalence among people with
CKD in our study suggests that this notion may also
apply to older populations. The easiest method to assess
Table 1 General characteristics of the study population (n = 2151) according to sex and prevalence of CKD. The quantitative values
are expressed by median and interquartile difference, qualitative values as number and percentage
Variable All
n = 2151
Men
n = 932
Women
n = 1219
CKD(−) group
n = 818
CKD(+) group
n = 1333
Age (years) 79.5 (5.9) 79.5 (5.8) 79.5 (5.9) 78.6 (4.5) 80.2 (6.2) c
Men (n, %) 932 (43.3) – – 315 (38.5) 617 (46.3) c
Education (years) 11 (7) 12 (7) 11 (7) a 12 (8) 11 (6) c
Weight (kg) 72.0 (17.5) 78 (15.6) 67 (16.3) c 70 (18.4) 74 (18.9) c
Arm circumference (cm) 28 (4.0) 28 (3.5) 28 (5.0) 28 (4.0) 28 (4.0) c
Waist circumference (cm) 98 (15) 102 (14) 95 (16) c 96 (15) 99 (16) c
Hip circumference (cm) 104 (11.0) 104 (9.0) 104 (14.0) a 102 (10.1) 105 (12.0) c
Calf circumference (cm) 36 (5.0) 37 (5.0) 35 (5.0) c 36 (5.0) 36 (6.0) c
BMI (kg/m2) 27.3 (5.6) 27.2 (5.0) 27.4 (6.3) 26.7 (5.4) 27.6 (5.7) c
WHR 0.93 (0.11) 0.98 (0.09) 0.89 (0.09) c 0.92 (0.12) 0.93 (0.11) c
WHtR 0.60 (0.10) 0.60 (0.09) 0.60 (0.10) 0.59 (0.10) 0.61 (0.09) c
MNA SF 13 (2) 14 (2) 13 (2) c 13 (2) 13 (2)
MNA 27.0 (3.0) 27.0 (2.5) 26.5 (3.0) c 27.0 (2.5) 26.5 (3.0) c
Albumin (g/dL) 4.22 (0.5) 4.30 (0.5) 4.20 (0.4) 4.30 (0.4) 4.20 (0.4) c
Diabetes (n,%) 532 (24.7) 279 (29.9) 253 (20.8) c 154 (18.8) 378 (28.4) c
Cancer (n,%) 368 (17.1) 188 (20.2) 180 (14.8) c 116 (14.2) 252 (18.9) b
Hypertension (n,%) 1635 (76.0) 707 (75.9) 928 (76.1) 542 (66.3) 1093 (82.0) c
CAD (n,%) 288 (13.4) 171 (18.3) 117 (9.6) c 72 (8.8) 216 (16.2) c
CVD (n,%) 268 (12.5) 132 (14.2) 136 (11.2) c 87 (10.6) 181 (13.6) a
HF (n,%) 335 (15.6) 167 (17.9) 168 (13.8) b 68 (8.3) 267 (20.0) c
COPD (n,%) 252 (11.7) 156 (16.7) 96 (7.9) c 70 (8.6) 182 (13.7) b
Metabolic syndrome (n,%) 1257 (58.4) 555 (59.5) 702 (57.6) 403 (49.3) 854 (64.1) c
CIRS-G 8 (6) 8 (7) 7 (7) c 7 (6) 9 (7) c
Country
Austria (n, %) 225 (10.5) 117 (12.6) 108 (8.9) b 30 (3.7) 195 (14.6) c
Germany (n, %) 270 (12.6) 83 (8.9) 187 (15.3) c 106 (13.0) 164 (12.3)
Israel (n, %) 299 (13.9) 138 (14.8) 161 (13.2) 149 (18.2) 150 (11.3) c
Italy (n, %) 436 (20.3) 221 (23.7) 215 (17.6) c 155 (18.9) 281 (21.1)
The Netherlands (n, %) 285 (13.2) 160 (17.2) 125 (10.3) c 90 (11.0) 195 (14.6) a
Poland (n, %) 352 (16.4) 101 (10.8) 251 (20.6) c 160 (19.6) 192 (14.4) b
Spain (n, %) 284 (13.2) 112 (12.0) 172 (14.1) 128 (15.6) 156 (11.7) b
a p < 0.05; b p < 0.01; c p < 0.001
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the occurrence of this type of obesity is the WC [41].
Central obesity was defined based on cut-off points ad-
vocated by Lean et al. (1995) as a WC of ≥102 cm in
men, and ≥ 88 cm in women [42]. Such WC are one of
the risk factors of metabolic syndrome, hypertension,
diabetes, which indirectly affects kidney function. In our
Table 2 General characteristics of men (n = 931) and women (n = 1217) according to eGFR category. The quantitative values are
expressed by median and interquartile difference, qualitative values as number and percentage
Variable Men Women
G1–2
(≥60)
N = 315
G3A
(45–59.9)
N = 368
G3B
(30–44.9)
N = 198
G4
(15–30)
N = 50
p-value* G1–2
(≥60)
N = 503
G3A
(45–59.9)
N = 483
G3B
(30–44.9)
N = 193
G4
(15–30)
N = 38
p-value*
Age (years) 78.7 (4.6) 79.6 (6.0) 80.1 (6.0) 83.2 (7.3) < 0.001abcdef 78.6 (4.4) 79.7 (5.7) 83.1 (7.9) 81.9 (6.8) < 0.001 abcdef
Education (years) 12 (8) 12 (7) 11 (6) 9 (5) 0.031 bcdef 12 (7) 11 (6) 10 (5) 8 (3) < 0.001 abcdef
Weight (kg) 77.0 (14.3) 78.0 (17.0) 81.4 (16.2) 75.5 (18.0) < 0.001 abcdef 65.0 (16.0) 67.0 (18.0) 69.4 (19.6) 72.7 (16.6) < 0.001 abcdef
Arm circumference
(cm)
28 (3.8) 28 (3.0) 29 (3.0) 28 (5.0) < 0.001 bdf 28 (4.5) 28 (4.5) 28 (5.0) 28 (5.0) < 0.001 bcde
Waist circumference
(cm)
100 (14.0) 101 (13.9) 104 (13.0) 102 (14.8) < 0.001 bdf 92 (17.0) 95 (16.0) 98 (16.0) 102 (13.2) < 0.001 abcdef
Hip circumference
(cm)
102 (9.0) 103 (9.0) 106 (9.0) 105 (10.0) < 0.001 bcde 102 (12.0) 105 (13.4) 108 (15.0) 111 (11.0) < 0.001 abcdef
Calf circumference
(cm)
36 (4) 36 (5) 38 (7) 42 (8) < 0.001 bcdef 35 (4) 36 (5) 36 (6) 41 (13) < 0.001 abcef
BMI (kg/m2) 26.9 (4.5) 27.2 (5.0) 27.7 (4.9) 26.7 (4.7) 0.011 abcef 26.6 (5.8) 27.6 (6.0) 28.5 (7.0) 29.6 (7.5) < 0.001 abcdef
WHR 1 (0.1) 1 (0.1) 1 (0.1) 1 (0.1) ns 0.89 (0.1) 0.89 (0.1) 0.89 (0.1) 0.90 (0.1) ns
WHtR 0.59 (0.1) 0.60 (0.1) 0.61 (0.1) 0.60 (0.1) < 0.001 bcdef 0.6 (0.1) 0.6 (0.1) 0.6 (0.1) 0.7 (0.1) < 0.001 cef
MNA SF 14 (2) 14 (1) 14 (2) 14 (3) ns 13 (2) 13 (2) 13 (2) 13 (3) ns
MNA 27 (2.5) 27 (2.5) 27 (2.5) 26 (4.7) < 0.001 cef 27 (3.0) 26.5 (3.5) 26 (3.0) 25.0 (6.2) < 0.001 c
Albumin (g/dL) 4.3 (0.4) 4.3 (0.4) 4.3 (0.4) 4.0 (0.5) < 0.001 cef 4.3 (0.4) 4.2 (0.5) 4.2 (0.5) 4.0 (0.6) < 0.001 c
Diabetes (n, %) 75 (23.8) 104 (28.3) 83 (41.9) 17 (34.0) < 0.001 abcdef 79 (15.7) 88 (18.2) 70 (36.3) 16 (42.1) < 0.001 abcdef
Cancer (n, %) 51 (16.2) 76 (20.7) 49 (24.7) 12 (24.0) ns 65 (12.9) 78 (16.1) 29 (15.0) 6 (15.8) ns
Hypertension (n, %) 201 (63.8) 281 (76.4) 177 (89.4) 47 (94.0) < 0.001 abcdef 341 (67.8) 378 (78.3) 169 (87.6) 38 (100.0) < 0.001 abcdef
CAD (n, %) 36 (21.2) 68 (40.0) 56 (32.9) 10 (5.9) < 0.001 abcdef 36 (7.2) 36 (7.5) 36 (18.7) 9 (23.7) < 0.001 bcdef
CVD (n, %) 39 (12.4) 57 (15.5) 30 (15.2) 6 (12.0) ns 48 (9.5) 49 (10.1) 30 (15.5) 9 (23.7) 0.009 bcdef
CHF (n, %) 26 (8.3) 74 (20.1) 51 (25.8) 15 (30.0) < 0.001 abcdef 42 (8.3) 75 (15.5) 40 (20.7) 11 (28.9) < 0.001 abcdef
COPD (n, %) 40 (12.7) 59 (16.0) 44 (22.2) 13 (26.0) 0.011 abcdef 30 (6.0) 36 (7.5) 25 (13.0) 5 (13.2) 0.012 abcdef
Metabolic syndrome
(n, %)
161 (51.1) 213 (57.9) 145 (73.2) 36 (72.0) < 0.001 abcdef 242 (48.1) 289 (59.8) 140 (72.5) 30 (78.9) < 0.001 abcdef
CIRS-G 7 (6) 8 (6) 10 (8) 12 (7) < 0.001 abcdef 6 (5) 7 (6) 11 (7) 12 (6) < 0.001 abcde
Country
Austria (n, %) 12 (3.8) 34 (9.2) 44 (22.2) 26 (52.0) < 0.001 abcdef 18 (3.6) 37 (7.7) 34 (17.6) 18 (47.4) < 0.001 abcdef
Germany (n, %) 32 (10.2) 35 (9.5) 12 (6.1) 4 (8.0) ns 74 (14.7) 69 (14.3) 39 (20.2) 5 (13.2) ns
Israel (n, %) 64 (20.3) 54 (14.7) 17 (8.6) 3 (6.0) 0.001 abcde 85 (16.9) 58 (12.0) 16 (8.3) 1 (2.6) 0.002 abcdef
Italy (n, %) 73 (23.2) 101 (27.4) 44 (22.2) 3 (6.0) 0.008 acdef 82 (16.3) 107 (22.2) 23 (11.9) 3 (7.9) 0.003 abcdef
The Netherlands
(n, %)
43 (13.7) 61 (16.6) 46 (23.2) 10 (20.0) 0.042 abcdef 47 (9.3) 40 (8.3) 32 (16.6) 6 (15.8) 0.008 cde
Poland (n, %) 49 (15.6) 42 (11.4) 10 (5.1) 0 (0.0) < 0.001 abcdef 111 (22.1) 115 (23.8) 25 (13.0) 0 (0.0) < 0.001 bcdef
Spain (n, %) 42 (13.3) 41 (11.1) 25 (12.6) 4 (8.0) ns 86 (17.1) 57 (11.8) 24 (12.4) 5 (13.2) ns
*p-values = based on comparisons between subgroups
a G1–2 (60 or more) vs G3A (45–59.9)
b G1–2 (60 or more) vs G3B (30–44.9)
c G1–2 (60 or more) vs G4 (15–30)
d G3A (45–59.9) vs G3B (30–44.9)
e G3A (45–59.9) vs G4 (15–30)
f G3B (30–44.9) vs G4 (15–30)
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Table 3 Spearmans correlations between nutritional status indicators and eGFR
Variable Correlation with GFR
All
Correlation with GFR
Men
Correlation with GFR
Women
Age (years) −0.274 b −0.257 b −0.286 b
Education (years) 0.106 b 0.066 b 0.150 b
Weight (kg) −0.164 b −0.098 b −0.152 b
Arm circumference (cm) −0.096 b −0.113 b − 0.086 b
Waist circumference (cm) − 0.186 b − 0.150 b − 0.160 b
Hip circumference (cm) − 0.168 b − 0.154 b − 0.189 b
Calf circumference (cm) − 0.167 b − 0.188 b − 0.131b
BMI (kg/m2) − 0.118 b − 0.073 a −0.153 b
WHR −0.100 b −0.053 − 0.045 a
WHtR −0.135 b − 0.122 b −0.145 b
MNA SF 0.018 0.023 0.031
MNA 0.111 b 0.102 b 0.134 b
Albumin (g/dL) 0.092 b 0.103 b 0.094 b
a p < 0.05; b p < 0.01
Fig. 1 Correlation between eGFR and a calf circumference, b albumin c waist-to-height ratio, d Mini Nutritional Assessment. a calf circumference
rho = −0.188 for men, and rho = − 0.131 for women, p < 0.01; b albumin rho = 0.103 for men, and rho = 0.094 for women, p < 0.01; c waist-to-
height ratio (WHtR) rho = − 0.122 for men, and rho = − 0.145 for women, p < 0.01; d Mini Nutritional Assessment (MNA) rho = 0.102 for men,
and rho = 0.134 for women, p < 0.01
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study, WC was strongly associated with CKD. Similarly
to the study of Evans et al., where researchers emphasize
that abdominal obesity is even more strongly associated
with CKD risk than BMI [43]. Although BMI is a con-
troversial indicator and there is ongoing discussion re-
garding the cut-off points for the older adults [44],
present analysis showed that the occurrence of kidney
disease is associated with higher BMI.
WHtR was another indicator that showed a link be-
tween CKD and obesity. This indicator is a universal
measure that can be used regardless of sex and race with
a cut-off value of WHtR = 0.5. The median for the CKD
(+) group was high (0.6 ± 0.1), and reached the highest
value of 0.7 ± 0.1 in the group of women in CKD stage
G4. In the meta-analyses done by Lee et al. [45] and
Correa et al. [46], WHtR was the best discriminator for
the risk of hypertension, diabetes, and dyslipidemia in
both sexes. WHtR can be simpler and more predictive
indicator of the cardiometabolic risk factors associated
with central obesity than other anthropometric indices
[47, 48]. In the present study WHtR showed the highest
odds ratio for the prediction of CKD. The increase of
WHtR by 0.1 increased the risk of kidney disease by
38%, and by 18% after adjustment for comorbidities.
This easy-to-count indicator can be recommended as a
CKD risk screening tool.
In contrast, WHR, as a body build indicator can
only be analysed separately for sexes and only for
participants categorized as obese in order to assess
obesity type [49, 50]. The lack of statistically signifi-
cant correlation between eGFR and WHR in men and
lack of statistical significance in logistic regression
analyses seems to suggest minor relevance of this
measure in older population.
Non-dominant middle arm circumference constitutes
a useful tool as a marker of malnutrition [51]. Our ana-
lysis showed a negative correlation with eGFR but it pre-
sented a small differentiation between eGFR categories
(about 1 cm). Additionally, AC may be loaded with one
of the highest anthropometric measurement errors [52].
Therefore, inference based on this result should be lim-
ited in older population.
Table 4 Logistic regression models (Odds ratios and corresponding 95% confidence intervals (95%CI)) for the association of CKD
and malnutrition: the presence of CKD (Model 1) predicted by nutritional and anthropometric variables, while malnutrition defined
with MNA < 24 (Model 2) and malnutrition defined with albumin < 3.5 g/dL (Model 3) predicted by CKD stages. Each model was
adjusted for age and sex (A), age, sex, concomitant diseases (diabetes mellitus, cancer, HF, CAD, CVD, COPD, metabolic syndrome)
and country (B)
Variables Model 1A
CKD
GRF < 60 ml/min/1.73 m2
Model 1B
CKD
GRF < 60 ml/min/1.73 m2
OR (95%CI)
age and sex adjusted
OR (95%CI)
age, sex, comorbiditiesa and country adjusted
Weight (kg) 1.03 (1.02–1.04) 1.02 (1.01–1.03)
Arm Circumference (cm) 1.10 (1.07–1.13) 1.07 (1.04–1.10)
Waist circumference (cm) 1.03 (1.02–1.03) 1.01 (1.00–1.02)
Hip circumference (cm) 1.03 (1.02–1.04) 1.02 (1.01–1.03)
Calf circumference (cm) 1.08 (1.06–1.10) 1.03 (1.00–1.06)
BMI (kg/m2) 1.07 (1.05–1.09) 1.05 (1.02–1.07)
WHR 1.10 (0.97–1.25) 0.99 (0.86–1.14)
WHtR 1.38 (1.22–1.56) 1.18 (1.01–1.38)
MNA 0.95 (0.92–0.99) 0.98 (0.94–1.00)
Albumin (g/dL) 0.73 (0.56–0.95) 0.73 (0.53–1.00)
Variables
CKD stages
GFR in ml/min/1.73 m2
Model 2A
malnutrition
MNA < 24
Model 2B
malnutrition
MNA < 24
Model 3A
malnutrition
albumin < 3.5
Model 3B
malnutrition
albumin < 3.5
OR (95%CI)
age and sex adjusted
OR (95%CI)
age, sex, comorbiditiesa and
country adjusted
OR (95%CI)
age and sex adjusted
OR (95%CI)
age, sex, comorbiditiesa
and country adjusted
CKD ≥60 1 1 1 1
CKD 45–59.9 1.12 (0.86–1.45) 1.03 (0.78–1.37) 2.05 (1.02–4.10) 1.70 (0.78–3.72)
CKD 30–44.9 1.51 (1.14–2.00) 1.28 (0.93–1.75) 2.21 (1.20–4.06) 1.71 (0.81–3.61)
CKD 15–30 3.15 (1.98–4.99) 2.95 (1.77–4.94) 3.70 (1.57–8.67) 5.54 (1.66–18.51)
a comorbidities: diabetes, cancer, HF, CAD, CVD, COPD, metabolic syndrome
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In contrast, the CC showed higher differentiation be-
tween eGFR categories. Differences found between sub-
groups according to the eGFR category, the highest
statistically significant correlation coefficients with eGFR
and statistical significance in logistic regression analyses
indicate a strong relationship between CC and kidney
function.
Men with eGFR 15–30 had lower BMI, WHtR and
WC as compared to the group of men with eGFR 30–
44.9, while the CC was definitely higher. This may be
due to the presence of oedema of the lower limbs that
accompanies advanced CKD. The lowest values of albu-
min observed in this group may also partly account for
this apparent discrepancy [53, 54]. In women, albumin
levels also decrease what is accompanied by an increase
in CC but at the same time weight, BMI and WHtR
were also higher. A detailed analysis of body compos-
ition should clarify those potential sex differences.
Albumin level and MNA were used as markers of nu-
tritional status and malnutrition. Decrease in albumin
level may be associated with a decrease in renal function
and loss of albumin in the urine. This phenomenon is
escalating with the progression of CKD [55]. Regression
analysis suggests that irrespective of confounders, an in-
crease in albumin of 1 g/dL reduces the likelihood of
CKD by 27%. Likewise, advanced CKD (eGFR < 30) in-
creases the likelihood of malnutrition (albumin < 3,5 g/
dL) more than three times (five times after adjusting for
comorbidities and country). This data confirms the
strong relationship between eGFR and albumin levels.
One of the most important findings was the poorer
MNA tests results in CKD participants. Generally, the
studied group of older people was relatively fit and with
good nutritional status. According to MNA score < 24 a
risk of malnutrition was observed in only 338 subjects
(15.7%). Nevertheless, this risk increased together with
reduced kidney function. Positive correlation for both
genders and also statistically lower MNA result in the
group with eGFR 15–30 indicates an increasing risk of
malnutrition in CKD subjects. In contrast, the MNA SF
screening test did not significantly correlate with eGFR
nor differ between eGFR stages, which may suggest lim-
ited application of MNA SF as malnutrition screening
tool in older adults 75+ [56].
Overall, findings from the present study may be rele-
vant to clinicians dealing with older patients. The assess-
ment of anthropometric measures and comorbidities
may help to identify patients at risk of negative cardio-
metabolic and renal outcomes to be referred to specific
care pathways aimed at reducing the burden of abdom-
inal obesity and other risk factors. On the other hand,
the identification of patients at risk of malnutrition is
equally relevant when considering the consequences of
malnutrition in terms of frailty, functional decline,
sarcopenia, falls, hospitalization and death. In both cases,
regular and careful monitoring of nutritional status
using validated instruments would be needed.
Limitations of our study deserve to be mentioned. The
cross-sectional design limits the interpretation of the ob-
served associations, and the analysis of currently ongoing
prospective phase of the SCOPE study may reveal differ-
ent results. The population in the initial study included
people with no advanced chronic kidney disease, and
therefore inferences may relate to risk factors rather
than symptoms in the final stages of CKD. We did not
analyze the impact of diet on our findings. The observa-
tion that excessive body weight, and especially visceral
obesity is associated with CKD, whereas malnutrition
may appear in advanced stage of chronic kidney disease
in both sexes suggests the need for a personalized diet
and appropriately selected physical activity to prevent
both malnutrition and obesity [3]. However, 24 h-dietary
recall data will be available within the SCOPE study and
warrants further analyses in this very interesting topic.
Body composition, as well as steroid hormones and
hypothalamic-pituitary-adrenal/gonadix axis were not
included in the present study. Nevertheless, both are
planned to be included in future studies within the
SCOPE project.
As for strength, we studied a real world population of
older people aged 75 or more enrolled without stringent
exclusion criteria who underwent a comprehensive as-
sessment of anthropometric and nutritional variables
measured by standardized methods.
Conclusions
The population of community dwelling 75+ with CKD
shows generally features of overweight and obesity with
small prevalence of malnutrition. For anthropometric
measures, the strongest association with eGFR and the
highest odds of CKD were identified using WC, HC, AC,
CC and WHtR. Albumin level and MNA, but not MNA
SF, indicated an increasing odds of malnutrition together
with decreasing eGRF.
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